Results 91 to 100 of about 16,893 (203)

Wilson’s Disease, Etiology and Treatment

International Journal of Medical Toxicology and Forensic Medicine
Background: Wilson’s disease is a chronic, gradually developed disease. Its concern is as an autosomal recessive inherited metabolic disorder. The deposition of copper in many organs, such as the liver, eyes, kidneys, and basal ganglia in the brain is ...
Feryal Rada
doaj  

Clinical Profile, Laboratory Characteristics and Treatment of Wilson’s Disease in Children from Western India

The Journal of Pediatric Academy
To study the clinical profile and laboratory characteristics and treatment of children with Wilson’s disease (WD). The current study was done at Department of pediatrics, Sir Padampat Institute of Neonatology and Pediatric Health, Sawai Man Singh Medical
Shailja Vajpayee, Alok Kumar Goyal, Yogesh Yadav, Ruchi Agarwal   +3 more
doaj   +1 more source

Osteoporosis in the rheumatoid hand the effects of treatment with D-penicillamine and oral gold salts [PDF]

, 2017
Osteoporosis is a common and important feature of rheumatoid disease which can be further influenced by the treatment admiflistered. o-penicillamine. a lathyritic agent.
Schorn, D.
core  

Penicillamine ameliorates intestinal barrier damage in dextran sulfate sodium-induced experimental colitis mice by inhibiting cuproptosis

Frontiers in Immunology
BackgroundCuproptosis is a copper-dependent form of cell death. However, its role in ulcerative colitis (UC) remains unknown.AimTo investigate whether cuproptosis is involved in UC and whether penicillamine (PA) improves colitis in mice by inhibiting ...
Jiaze Ma, Yimeng Ma, Shuangshuang Wang, Wenwen Tang, Chen Chen, Yang Li, Yang Li, Yugen Chen, Tuo Chen   +8 more
doaj   +1 more source

Penicillamine and Cystinuria [PDF]

BMJ, 1964
openaire   +2 more sources

Guillain-Barré syndrome and pemphigus foliaceus associated with D-penicillamine therapy

, 1984
The Guillain-Barré syndrome and pemphigus foliaceus occurred simultaneously in a patient on long-term treatment with D-penicillamine. It is proposed that both conditions may have developed as a result of a disturbance of immunoregulation caused by D ...
Mastaglia, F.L., Quintner, J., Zilko, P.J., Knezevicˇ, W.   +3 more
core  

PENICILLAMINE AND VITAMIN B₆INTERRELATIONSHIPS IN THE RAT

, 1963
DL-Penicillamine administered in the diet at the 0.25% level produced a marked lowering of food intake and body weight. Using blood transaminase activities as criteria, a definite antagonism to vitamin B6was demonstrated.
J. G. Heddle, G. H. Beaton, E. W. McHenry   +2 more
core   +1 more source

Urinary copper at 1 month predicts early neurological worsening in treatment-naïve Wilson’s disease on ultra-low dose penicillamine

Frontiers in Neurology
BackgroundPenicillamine can trigger early neurological worsening in patients with Wilson’s disease (WD). We evaluated a very conservative regimen, starting at 125 mg/day and increasing the does stepwise at months 1, 3, and 6, combined with zinc, focusing
Yue Luo, Mansi Cai, Jie Yang, Xiangxue Zhou, Chao Wu, Huajing You, Xunhua Li, Dingbang Chen   +7 more
doaj   +1 more source

Penicillamine-induced elastosis perforans serpiginosa and pseudo-pseudoxanthoma elasticum

International Journal of Women's Dermatology, 2021
Lauren E. Heusinkveld, BS, Daniel Michalik, MD, Jennifer Lucas, MD   +2 more
doaj   +1 more source

Penicillamine in 1980 [PDF]

Acta Medica Scandinavica, 1981
openaire   +2 more sources